Top Markets
Coin of the day
Pardes Biosciences, Inc. Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

PRDS
Rangering i aksjer #20774
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated... Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses. Its primary investigational therapy, PBI-0451, is currently progressing through clinical development with the aim of both treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their related health issues. Established in 2020, Pardes Biosciences maintains its corporate headquarters in Carlsbad, California.
Aksjekurs
$2.16
Sist synkronisert: 2023-09-08
Markedsverdi
$122.36M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Pardes Biosciences, Inc. (PRDS)

Kategori

P/S-forhold for Pardes Biosciences, Inc. (PRDS)
P/S-forhold per 2026 TTM: 0
Ifølge Pardes Biosciences, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Pardes Biosciences, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH